Cargando…
Characteristic promoter hypermethylation signatures in male germ cell tumors
BACKGROUND: Human male germ cell tumors (GCTs) arise from undifferentiated primordial germ cells (PGCs), a stage in which extensive methylation reprogramming occurs. GCTs exhibit pluripotentality and are highly sensitive to cisplatin therapy. The molecular basis of germ cell (GC) transformation, dif...
Autores principales: | Koul, Sanjay, Houldsworth, Jane, Mansukhani, Mahesh M, Donadio, Alessia, McKiernan, James M, Reuter, Victor E, Bosl, George J, Chaganti, Raju S, Murty, Vundavalli V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149411/ https://www.ncbi.nlm.nih.gov/pubmed/12495446 http://dx.doi.org/10.1186/1476-4598-1-8 |
Ejemplares similares
-
Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors
por: Koul, Sanjay, et al.
Publicado: (2004) -
Subtyping of renal cortical neoplasms in fine needle aspiration biopsies using a decision tree based on genomic alterations detected by fluorescence in situ hybridization
por: Gowrishankar, Banumathy, et al.
Publicado: (2014) -
Development and Validation of a Gene-Based Model for Outcome Prediction in Germ Cell Tumors Using a Combined Genomic and Expression Profiling Approach
por: Korkola, James E., et al.
Publicado: (2015) -
Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression
por: Narayan, Gopeshwar, et al.
Publicado: (2006) -
Reduced Proficiency in Homologous Recombination Underlies the High Sensitivity of Embryonal Carcinoma Testicular Germ Cell Tumors to Cisplatin and Poly (ADP-Ribose) Polymerase Inhibition
por: Cavallo, Francesca, et al.
Publicado: (2012)